Cyanidin-3-O-glucoside attenuates acute lung injury in sepsis rats

Journal of Surgical Research

Volumn 199, Issue 2, 2015, Pages 592-600

  Yan, Xuerui ^a   Wu, Lin ^b   Li, Bin ^a   Meng, Xianjun ^a   Dai, Hanping ^a   Zheng, Yanan ^a   Fu, Junfan ^a  

^a SHENYANG AGRICULTURAL UNIVERSITY   (China)

^b Jilin Province Pulan High Tech Co   (China)

Author keywords

Acute lung injury; Cyanidin 3 O Glucoside; Inflammation; nuclear factor kappa B; Oxidative stress; Sepsis

Indexed keywords

ANTHOCYANIN; CYANIDIN 3-O-GLUCOSIDE; GLUCOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACUTE LUNG INJURY; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG SCREENING; IMMUNOLOGY; LUNG; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RANDOMIZATION; SEPSIS; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; ANTHOCYANINS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GLUCOSIDES; LUNG; MALE; NF-KAPPA B; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 85027956398     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.06.013     Document Type: Article

References (45)

1. Adhikari, N.K., Fowler, R.A., Bhagwanjee, S., Rubenfeld, G.D., Critical care and the global burden of critical illness in adults. Lancet, 376, 2010, 1339.
2. Angus, D.C., van der Poll, T., Severe sepsis and septic shock. N Engl J Med, 369, 2013, 840.
3. Abraham, E., Singer, M., Mechanisms of sepsis-induced organ dysfunction. Crit Care Med, 35, 2007, 2408.
4. Pinsky, M.R., Sepsis and multiple organ failure. Contrib Nephrol, 156, 2007, 47.
5. Raghavendran, K., Napolitano, L.M., Definition of ALI/ARDS. Crit Care Clin, 27, 2011, 429.
6. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M.R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 29, 2001, 1303.
7. Ware, L.B., Matthay, M.A., The acute respiratory distress syndrome. N Engl J Med, 342, 2000, 1334.
8. Hudson, L.D., Milberg, J.A., Anardi, D., Maunder, R.J., Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med, 151, 1995, 293.
9. Rubenfeld, G.D., Caldwell, E., Peabody, E., et al. Incidence and outcomes of acute lung injury. N Engl J Med, 353, 2005, 1685.
10. Sevransky, J.E., Martin, G.S., Shanholtz, C., et al. Mortality in sepsis versus non-sepsis induced acute lung injury. Crit Care, 13, 2009, R150.
11. Sevransky, J.E., Levy, M.M., Marini, J.J., Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med, 32, 2004, S548.
12. Dolinay, T., Kim, Y.S., Howrylak, J., et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med, 185, 2012, 1225.
13. Bhargava, M., Wendt, C.H., Biomarkers in acute lung injury. Transl Res, 159, 2012, 205.
14. Budinger, G.R., Mutlu, G.M., Urich, D., et al. Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med, 183, 2011, 1043.
15. Shaughnessy, K.S., Boswall, I.A., Scanlan, A.P., Gottschall-Pass, K.T., Sweeney, M.I., Diets containing blueberry extract lower blood pressure in spontaneously hypertensive stroke-prone rats. Nutr Res, 29, 2009, 130.
16. Kalt, W., Foote, K., Fillmore, S.A., Lyon, M., Van Lunen, T.A., McRae, K.B., Effect of blueberry feeding on plasma lipids in pigs. Br J Nutr, 100, 2008, 70.
17. de Pascual-Teresa, S., Moreno, D.A., Garcia-Viguera, C., Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int J Mol Sci, 11, 2010, 1679.
18. Stoner, G.D., Wang, L.S., Casto, B.C., Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis, 29, 2008, 1665.
19. Diaconeasa, Z., Leopold, L., Rugina, D., Ayvaz, H., Socaciu, C., Antiproliferative and antioxidant properties of anthocyanin rich extracts from blueberry and blackcurrant juice. Int J Mol Sci, 16, 2015, 2352.
20. Serraino, I., Dugo, L., Dugo, P., et al. Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci, 73, 2003, 1097.
21. Speciale, A., Canali, R., Chirafisi, J., Saija, A., Virgili, F., Cimino, F., Cyanidin-3-O-glucoside protection against TNF-α-induced endothelial dysfunction: involvement of nuclear factor-κB signaling. J Agric Food Chem, 58, 2010, 12048.
22. Min, J., Yu, S.W., Baek, S.H., et al. Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia. Neurosci Lett, 500, 2011, 157.
23. Qin, L., Zhang, J., Qin, M., Protective effect of cyanidin 3-O-glucoside on beta-amyloid peptide-induced cognitive impairment in rats. Neurosci Lett, 534, 2013, 285.
24. Speciale, A., Anwar, S., Canali, R., et al. Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway. Mol Nutr Food Res, 57, 2013, 1979.
25. Rossi, A., Serraino, I., Dugo, P., et al. Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation. Free Radic Res, 37, 2003, 891.
26. Fu, Y., Zhou, E., Wei, Z., et al. Cyanidin-3-O-beta-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts. Biochem Pharmacol, 90, 2014, 126.
27. Hu, Z., Gu, Z., Sun, M., et al. Ursolic acid improves survival and attenuates lung injury in septic rats induced by cecal ligation and puncture. J Surg Res, 194, 2015, 528.
28. Irish Critical Care Trials Group. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care, 12, 2008, R30.
29. Zambon, M., Vincent, J.L., Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest, 133, 2008, 1120.
30. Zambon, M., Vincent, J.L., Are outcomes improving in patients with ARDS?. Am J Respir Crit Care Med, 180, 2009, 1158.
31. Tasaka, S., Hasegawa, N., Ishizaka, A., Pharmacology of acute lung injury. Pulm Pharmacol Ther, 15, 2002, 83.
32. Steinberg, K.P., Milberg, J.A., Martin, T.R., Maunder, R.J., Cockrill, B.A., Hudson, L.D., Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med, 150, 1994, 113.
33. Weiland, J.E., Davis, W.B., Holter, J.F., Mohammed, J.R., Dorinsky, P.M., Gadek, J.E., Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis, 133, 1986, 218.
34. Kinnula, V.L., Crapo, J.D., Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med, 167, 2003, 1600.
35. Wang, P., Ye, X.L., Liu, R., et al. Mechanism of acute lung injury due to phosgene exposition and its protection by caffeic acid phenethyl ester in the rat. Exp Toxicol Pathol, 65, 2013, 311.
36. Moldawer, L.L., Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis. Blood Purif, 11, 1993, 128.
37. Aikawa, N., Takahashi, T., Fujimi, S., et al. A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock. J Infect Chemother, 19, 2013, 931.
38. Lomas-Neira, J., Perl, M., Venet, F., Chung, C.S., Ayala, A., The role and source of tumor necrosis factor-α in hemorrhage-induced priming for septic lung injury. Shock, 37, 2012, 611.
39. Vanden Berghe, T., Demon, D., Bogaert, P., et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med, 189, 2014, 282.
40. Ang, S.F., Sio, S.W., Moochhala, S.M., MacAry, P.A., Bhatia, M., Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin E metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation. J Immunol, 187, 2011, 4778.
41. Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L.E., Levy, B.D., Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol, 174, 2005, 5033.
42. Aderem, A., Ulevitch, R.J., Toll-like receptors in the induction of the innate immune response. Nature, 406, 2000, 782.
43. Liang, Y., Zhou, Y., Shen, P., NF-kappaB and its regulation on the immune system. Cell Mol Immunol, 1, 2004, 343.
44. Sheehan, M., Wong, H.R., Hake, P.W., Zingarelli, B., Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med, 31, 2003, 2263.
45. Alvira, C.M., Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions. Birth Defects Res A Clin Mol Teratol, 100, 2014, 202.